Showing results (51-60 of 169) with videos related to

Sort By:
Pageof 17
Cancer Research|February 9, 2022
Neoadjuvant Intratumoral Immunotherapy with TLR9 Activation and Anti-OX40 Antibody Eradicates Metastatic CancerWan Xing Hong, Idit Sagiv-Barfi, Debra K Czerwinski, et al.
Biochemical Society Transactions|April 15, 2017
CD81 as a tumor targetFelipe Vences-Catalán, Caroline Duault, Chiung-Chi Kuo, et al.
Science Immunology|May 27, 2022
Intratumoral immunotherapy relies on B and T cell collaborationIdit Sagiv-Barfi, Debra K Czerwinski, Tanaya Shree, et al.
International Journal of Cancer|September 25, 2008
Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cellsWeiyun Z Ai, Jing-Zhou Hou, Robert Zeiser, et al.
Leukemia & Lymphoma|August 1, 2002
Mutation of the ATM gene is not involved in the pathogenesis of either follicle center lymphoma or its transformation to higher-grade lymphomaIzidore S Lossos, Yvonne R Thorstenson, Tierney L Wayne, et al.
The Journal of Molecular Diagnostics : JMD|July 27, 2007
''Minor'' BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease presentation in 236 casesOlga K Weinberg, Weiyun Z Ai, M Rajan Mariappan, et al.
Seminars in Radiation Oncology|December 8, 2014
Current clinical trials testing combinations of immunotherapy and radiationMarka Crittenden, Holbrook Kohrt, Ronald Levy, et al.
Biochemical and Biophysical Research Communications|October 27, 2009
Cell-free production of Gaussia princeps luciferase--antibody fragment bioconjugates for ex vivo detection of tumor cellsKedar G Patel, Patrick P Ng, Chiung-Chi Kuo, et al.
The American Journal of Surgical Pathology|August 11, 2010
Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse componentsSheren F Younes, Andrew H Beck, Izidore S Lossos, et al.
Pageof 17